Company Overview of CGI Pharmaceuticals, Inc.
CGI Pharmaceuticals, Inc., a development-stage pharmaceutical company, discovers and develops small molecule therapeutics for multiple oncology and immunology-based indications. The company provides drug discovery and development programs, including Btk, a B-cell kinase for a range of AAID and oncology indications; and Syk, a regulator of mast cell, monocyte/macrophage, and B-cell functions. The company was formerly known as Cellular Genomics, Inc. and changed its name to CGI Pharmaceuticals, Inc. in September, 2005. The company was founded in 1998 and is headquartered in Branford, Connecticut. As of July 8, 2010, CGI Pharmaceuticals, Inc. operates as a subsidiary of Gilead Sciences Inc.
36 East Industrial Road
Branford, CT 06405
Founded in 1998
Key Executives for CGI Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Protein Sciences Corporation||United States|
|LSK BioPartners, Inc.||United States|
|The Tapemark Company||United States|
|Symbiance, Inc.||United States|
|Edusa Pharmaceuticals, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact CGI Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.